Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Sofosbuvir and velpatasvir

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 5Epclusa

    02 1Vosevi

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Epclusa

    Sofosbuvir and Velpatasvir

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Epclusa

    U.S.A
    arrow
    Antibody Engineering
    Not Confirmed

    Gilead

    Sofosbuvir and Velpatasvir

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 1,599

    2019 Revenue in Millions : 1,965

    Growth (%) : -19

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Epclusa

    Sofosbuvir And Velpatasvir

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Epclusa

    U.S.A
    arrow
    Antibody Engineering
    Not Confirmed

    Gilead

    Sofosbuvir And Velpatasvir

    Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

    Currency : USD

    2016 Revenue in Millions : 1,752

    2015 Revenue in Millions : Not Reported

    Growth (%) : New Launch

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Epclusa

    Sofosbuvir and Velpatasvir

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Epclusa

    U.S.A
    arrow
    Antibody Engineering
    Not Confirmed

    Gilead

    Sofosbuvir and Velpatasvir

    Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

    Currency : USD

    2017 Revenue in Millions : 3,510

    2016 Revenue in Millions : 1,752

    Growth (%) : 100

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Vosevi

    Sofosbuvir 400 mg/Velpatasvir 100 mg/Voxilaprevir 100 mg

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Vosevi

    U.S.A
    arrow
    Antibody Engineering
    Not Confirmed

    Gilead

    Sofosbuvir 400 mg/Velpatasvir 100 mg/Voxilaprevir 100 m...

    Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

    Currency : USD

    2017 Revenue in Millions : 293

    2016 Revenue in Millions : New Launch

    Growth (%) : New Launch

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Epclusa

    Sofosbuvir And Velpatasvir

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Epclusa

    U.S.A
    arrow
    Antibody Engineering
    Not Confirmed

    Gilead

    Sofosbuvir And Velpatasvir

    Main Therapeutic Indication : Infectious Diseases (HIV, Hepatitis...

    Currency : USD

    2018 Revenue in Millions : 1,966

    2017 Revenue in Millions : 3,510

    Growth (%) : -44%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Epclusa

    Sofosbuvir and Velpatasvir

    arrow
    Antibody Engineering
    Not Confirmed

    Brand Name : Epclusa

    U.S.A
    arrow
    Antibody Engineering
    Not Confirmed

    Gilead

    Sofosbuvir and Velpatasvir

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2019 Revenue in Millions : 1,965

    2018 Revenue in Millions : 1,966

    Growth (%) : 0

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF